{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-110168","form_type":"8-K","ticker":"BTSG","cik":"0001865782","company_name":"BrightSpring Health Services, Inc.","filed_at":"2024-09-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.010730+00:00","generated_at":"2026-05-31T00:54:13.347621+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"BrightSpring Health Services appoints Dr. Steve Miller to Board of Directors","bullets":["Dr. Steve Miller appointed as Class II director on September 27, 2024; board expands from 7 to 8 members.","Miller will serve on Audit Committee and chair Quality & Compliance and Governance Committee.","Former Chief Clinical Officer of Cigna (2018-2022) and CMO of Express Scripts (2005-2018).","No transactions requiring disclosure under Item 404(a) between Miller and the company."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-110168","json":"https://secwatch.observer/filing/0000950170-24-110168.json","markdown":"https://secwatch.observer/filing/0000950170-24-110168.md","text":"https://secwatch.observer/filing/0000950170-24-110168.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1865782/000095017024110168/0000950170-24-110168-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1865782/000095017024110168/btsg-20240927.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T00:54:13.347621+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ee2d09ab52","claim":"Dr. Steve Miller was appointed as Class II director at BrightSpring Health Services, Inc..","evidence_excerpt":"On September 27, 2024, the board of directors (the “Board”) of BrightSpring Health Services, Inc. (the “Company”) increased the number of directors serving on the Board from seven (7) to eight (8) members and appointed Dr. Steve Miller to the Board as a Class II director to fill the resulting vacancy.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1865782/000095017024110168/0000950170-24-110168-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class II director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}